July 25 (Reuters) - Schrole Group Ltd (SCL) : ARR AT END OF JUNE A$4.4M UP FROM A$4.2M AT END OF MARCH (([email protected];))
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status